Intended for healthcare professionals

Letters Post-colonoscopy colorectal cancer

Post-colonoscopy colorectal cancer: patients can be reassured that UK endoscopy is already engaged in quality assessment and continual improvement

BMJ 2019; 367 doi: https://doi.org/10.1136/bmj.l6910 (Published 10 December 2019) Cite this as: BMJ 2019;367:l6910
  1. Christopher J Healey, chair1,
  2. Siwan Thomas-Gibson, chair2
  1. 1Endoscopy Services Quality Assurance Group, Royal College of Physicians, London NW1 4LE, UK
  2. 2Joint Advisory Group on Gastrointestinal Endoscopy, Royal College of Physicians, London NW1 4LE, UK
  1. Chris.Healey{at}anhst.nhs.uk

Burr and colleagues suggest that quality improvement is needed to reduce variation in colonoscopy performance, as measured by post-colonoscopy colorectal cancer (PCCRC).1 This inter-hospital variation in colonoscopy quality has been known to UK gastroenterology since being shared by Roland Valori during the 2014 British Society of Gastroenterology (BSG) annual meeting. The importance of ensuring that colonoscopy does find bowel cancer consistently …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription